Besivance Suspension
Product Images NDC 85766-257

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 85766-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Besifloxacin Hydrochloride Structural Formula (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)

Besifloxacin Hydrochloride Structural Formula (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)
Chemical structure of Besifloxacin hydrochloride, the active ingredient in Besivance ophthalmic suspension 6 mg/mL by Sportpharm LLC. The structure shows the fluorinated quinolone antibiotic molecule with a cyclopropyl group and a hydrochloride salt.*
FDA Label Image

1 (Label)

1 (Label)
Packaging label for Besivance (besifloxacin ophthalmic suspension) 0.6% by Sportpharm LLC. The label shows NDC 85766-257-05, a quantity of 5, and indicates distribution by Bausch & Lomb Americas Inc. It includes barcode and batch information on a 5 mL sterile ophthalmic suspension bottle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.